In phase II studies Apatorsen improved outcomes in bladder, prostate cancers

Partial gland removal for prostate cancer patients may avoid recurrence, study shows

A five-year study on subjects who had only the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual function.

March 07, 2025

Vol.51 No.09

Clinical Roundup

Immunotherapy may have potential as prostate cancer treatment, study shows

A study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined with a synergistic treatment approach.

March 07, 2025

Vol.51 No.09

Black History Month Conversation with The Cancer Letter

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”

Nearly 30 years ago, while completing an assignment for his master’s degree in public health, Brian Rivers discovered he had a family history of prostate cancer.

Immunotherapy + radiation show promise for bladder preservation in localized MIBC, phase II study shows

Patients with localized muscle-invasive bladder cancer who received radiation plus the immune checkpoint inhibitors durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses that allowed for bladder preservation, according to results from the IMMUNOPRESERVE clinical study published in Clinical Cancer Research, a journal of the AACR.

February 21, 2025

Vol.51 No.07

Clinical Roundup

Talzenna + Xtandi improve OS in metastatic castration-resistant prostate cancer, phase III study finds

Pfizer Inc. announced positive results from the phase III TALAPRO-2 study of Talzenna (talazoparib), an oral poly ADP-ribose polymerase inhibitor, in combination with Xtandi (enzalutamide), an androgen receptor pathway inhibitor, demonstrating a statistically significant and clinically meaningful improvement in overall survival compared to placebo plus Xtandi in patients with metastatic castration-resistant prostate cancer, with or without homologous recombination repair gene mutations.

February 14, 2025

Vol.51 No.06

Clinical Roundup

Chemo + immunotherapy may improve bladder preservation, interim data from phase II study show

Interim analysis of a clinical trial led by Fox Chase Cancer Center researchers shows promise for the treatment of patients with muscle-invasive bladder cancer.

February 14, 2025

Vol.51 No.06

In phase II studies Apatorsen improved outcomes in bladder, prostate cancers

YOU MAY BE INTERESTED IN

Partial gland removal for prostate cancer patients may avoid recurrence, study shows

Immunotherapy may have potential as prostate cancer treatment, study shows

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”

Immunotherapy + radiation show promise for bladder preservation in localized MIBC, phase II study shows

Talzenna + Xtandi improve OS in metastatic castration-resistant prostate cancer, phase III study finds

Chemo + immunotherapy may improve bladder preservation, interim data from phase II study show

Renew today!

Subscriber content

Never miss an issue!

Login

In phase II studies Apatorsen improved outcomes in bladder, prostate cancers

YOU MAY BE INTERESTED IN

Partial gland removal for prostate cancer patients may avoid recurrence, study shows

Immunotherapy may have potential as prostate cancer treatment, study shows

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America“It gives America, in part, its identity.”

Immunotherapy + radiation show promise for bladder preservation in localized MIBC, phase II study shows

Talzenna + Xtandi improve OS in metastatic castration-resistant prostate cancer, phase III study finds

Chemo + immunotherapy may improve bladder preservation, interim data from phase II study show

Never miss an issue!

Login

Brian Rivers: Celebrating Black history reinforces the dynamic culture of America
“It gives America, in part, its identity.”